Mapping of the bovine immunodeficiency virus packaging signal and RRE and incorporation into a minimal gene transfer vector

Virology

Volumn 304, Issue 1, 2002, Pages 10-23

  Molina, Rene P ^a   Matukonis, Meghan ^a   Paszkiet, Brian ^a   Zhang, Jingli ^a   Kaleko, Michael ^a   Luo, Tianci ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Bovine immunodeficiency virus; Lentiviral vector; Packaging signal; Rev response element

Indexed keywords

GAG PROTEIN; LENTIVIRUS VECTOR; POL PROTEIN; TRANSACTIVATOR PROTEIN; VIF PROTEIN;

ANIMAL CELL; ARTICLE; BOVINE IMMUNODEFICIENCY LIKE VIRUS; CELL CULTURE; CELL DIVISION; CELL LINE; CONTROLLED STUDY; DNA PACKAGING; DNA RESPONSIVE ELEMENT; EMBRYO; GENE CONSTRUCT; GENE MAPPING; GENE TRANSFER; GENETIC CODE; GENETIC TRANSDUCTION; HEPATITIS VIRUS; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

BOVINAE; BOVINE IMMUNODEFICIENCY VIRUS; MARMOTA MONAX; PRIMATES;

EID: 0036944376     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1688     Document Type: Article

References (57)

1. Aldovini, A., and Young, R. A. (1990). Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64, 1920-1926.
2. Berkowitz, R. D., Ilves, H., Plavec, I., and Veres, G. (2001a). Gene transfer systems derived from Visna virus: Analysis of virus production and infectivity. Virology 279, 116-129.
3. Berkowitz, R. D., Ilves, H., Lin, W. Y., Eckert, K., Coward, A., Tamaki, S., Veres, G., and Plavec, I. (2001b). Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus. J. Virol. 75, 3371-3382.
4. Blomer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., and Gage, F. H. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649.
5. Buchschacher, G. L., and Wong-Staal, F. (2000). Development of lentiviral vectors for gene therapy for human disease. Blood 95, 2499-2504.
6. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J. K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retro-viral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037.
7. Carswell, S., and Alwine, J. C. (1989). Efficiency of utilization of the simian virus 40 late polyadenylation site: Effects of upstream sequences. Mol. Cell. Biol. 241, 651-662.
8. Clavel, F., and Orenstein, J. M. (1990). A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J. Virol. 64, 5230-5234.
9. Cullen, B. (1998). Minireview: Retroviruses as model systems for the study of nuclear RNA export pathways. Virology 249, 203-210.
10. Curran, M. A., Kaiser, S. M., Achacoso, P. L., and Nolan, G. P. (2000). Efficient transduction of non-dividing cells by optimised feline immunodeficiency virus vectors. Mol. Ther. 1, 31-38.
11. Deglon, N., Tseng, J. L., Bensadoun, J.-C., Zurn, A. D., Arsenijevic, Y., de Almeida, L. P., Zufferey, R., Trono, D., and Abeischer, P. (2000). Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum. Gene Ther. 11, 179-190.
12. + cells via human immunodeficiency virus-based gene transfer vectors. Hum. Gene Ther. 10, 395-945.
13. Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., and Naldini, L. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471.
14. Galileo, D. S., Hunter, K., and Smith, S. B. (1999). Stable and efficient gene transfer into the mutant retinal pigment epithelial cells of the MitF (vit) mouse using a lentiviral vector. Curr. Eye Res. 18, 135-142.
15. Gallardo, H. F., Tan, C., Ory, D., and Sadelain, M. (1997). Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90, 952-957.
16. Gallichan, W. S., Kafri, T., Krahl, T., Verma, I. M., and Sarvetnick, N. (1998). Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene. Hum. Gene Ther. 10, 2717-2726.
17. Garvey, K. J., Oberste, M. S., Elser, J. E., Braun, M. J., and Gonda, M. A. (1990). Nucleotide sequence and genome organization of biologically-active proviruses of the bovine immunodeficiency-like virus. Virology 175, 391-409.
18. Gonda, M. A., Luther, D. G., Fong, S. E., and Tobin, G. J. (1994). Bovine immunodeficiency virus: Molecular biology and virus-host interactions. Virus Res. 32, 155-181.
19. Johnston, J. C., Gasmi, M., Lim, L. E., Elder, J. H., Yee, J. K., Jolly, D. J., Campbell, K. P., Davidson, B. L., and Sauter, S. L. (1999). Minimum requirements for efficient transduction of dividing and non-dividing cells by feline immunodeficiency virus vectors. J. Virol. 73, 4991-5000.
20. Kafri, T., Blomer, D. A., Peterson, A., Gage, F. H., and Verma, I. M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314-317.
21. Kalvatchev, Z., Walder, R., Barrios, M., and Garzaro, D. (1995). Acquired immune dysfunction in rabbits experimentally infected with an infectious molecular clone of the bovine immunodeficiency virus (BIV127). Viral Immunol. 8, 159-164.
22. Kestler, H. W., III, Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., and Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
23. Kordower, J. H., Emborg, M. E., Bloch, J., Ma, A. Y., Chu, Y., Leventhal, L., Mcbride, J., Chen, E-Y., Palfi, S., Roitberg, B. Z., Brown, W. D., Holden, J. E., Pyzalski, R., Taylor, M. D., Carvey, P., Ling, Z. D., Trono, D., Hantraye, P., Deglon, N., and Abeischer, P. (2000). Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-773.
24. Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., and Mitrophanous, K. A. (2000). A rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74, 4839-4852.
25. Lever, A., Gottlinger, H., Haseltine, W., and Sodroski, J. (1989). Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63, 4085-4087.
26. Lewis, P., Hensel, M., and Emerman, M. (1992). Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11, 3053-3058.
27. Lewis, P., and Emerman, M. (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68, 510-516.
28. Liu, M. L., Winther, B., and Kay, M. A. (1996). Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: Comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J. Virol. 70, 2497-2502.
29. Luban, J., and Goff, S. P. (1994). Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J. Virol. 68, 3203-3212.
30. Luciw, P. A. (1996). Human immunodeficiency viruses and their replication. In "Fields Virology" (B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roisman, and S. E. Straus, Eds.), 3rd ed., pp. 1881-1975. Lippincott-Raven, Philadelphia.
31. Mangeot, P. E., Negre, D., Dubois, B., Winter, A. J., Leissner, P., Mehtali, M., Kaiserlian, D., Cosset, F. L., and Darlix, J. L. (2000). Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J. Virol. 74, 8307-8315.
32. Miller, D. G., Adam, M. A., and Miller, A. D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell Biol. 10, 4239-4242.
33. Mitrophanous, K., Yoon, S., Rohll, J., Patil, D., Wilkes, F., Kim, V., Kingsman, S., Kingsman, A., and Mazarakis, N. (1999). Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6, 1808-1818.
34. Miyoshi, H., Takahashi, M., Gage, F. H., and Verma, I. M. (1997). Stable and efficient gene transfer into the retina using an HIV-based lenti-viral vector. Proc. Natl. Acad. Sci. USA 94, 10319-10323.
35. Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996a). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11382-11388.
36. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., and Trono, D. (1996b). In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272, 263-267.
37. Oberste, M. S., Williamson, J. C., Greenwood, J. D., Nagashima, K., Copeland, T. D., and Gonda, M. A. (1993). Characterization of bovine immunodeficiency virus rev cDNAs and identification and subcellular localization of the rev protein. J. Virol. 67, 6395-6405.
38. Olsen, J. C. (1998). Gene transfer vectors derived from equine infectious anemia virus. Gene Ther. 5, 1481-1487.
39. Parolin, C. P., Dorfman, T., Palu, G., Gottlinger, H., and Sodroski, J. (1994). Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol. 68, 3888-3895.
40. Poeschla, E., Wong-Staal, F., and Looney, D. (1998). Efficient transduc-tion of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4, 354-357.
41. Poznansky, M., Lever, A., Bergeron, L., Hazeltine, W., and Sodroski, J. (1991). Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 65, 532-536.
42. Reiser, J., Harmison, G., Kluepfel-Stahl, S., Brady, R. O., Karlsson, S., and Schubert, M. (1996). Transduction of non-dividing cells pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93, 15266-15271.
43. Roe, T., Reynolds, T. C., Yu, G., and Brown, P. O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099-2108.
44. Schwartz, S., Felber, B. K., and Pavlakis, G. N. (1992). Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of REV protein. J. Virol. 66, 150-159.
45. St. Cyrcoats, K., Pruett, S. B., Nash, J. W., and Cooper, C. R. (1994). Bovine immunodeficiency virus: Incidence of infection in Mississippi dairy cattle. Vet. Microbiol. 42, 181-189.
46. Takahashi, K., Luo, T., Saishin, Y., Saishin, Y., Sung, J., Hackett, S., Brazzell, P. K., Kaleko, M., and Campochiaro, P. (2002). Sustained transduction of ocular cells with a bovine immunodeficiency viral vector. Hum. Gene Ther. 13, 1305-1316.
47. Takahashi, M., Mitoshi, H., Verma, I., and Cage, F. H. (1999). Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J. Virol. 73, 7812-7816.
48. Trono, D. (2000). Lentiviral vectors: Turning a deadly foe into a therapeutic agent. Gene Ther. 7, 20-23.
49. Trono, D. (1995). HIV accessory proteins: Leading roles for the supporting cast. Cell 82, 189-192.
50. 1 human hematopoietic stem cells.) Proc. Natl. Acad. Sci. USA 95, 11939-11944.
51. Wagner, R., Graf, M., Bieler, K., Wolf, H., Grunwald, T., Foley, P., and Uberla, K. (2000). Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: Implications for the safety of lentiviral vectors. Hum. Gene Ther. 11, 2403-2413.
52. Walder, R., Kalvatchev, Z., Perez, F., Garzaro, D., and Barrios, M. (2001). Bovine immunodeficiency virus in experimentally infected rabbits: Tropism for lymphoid and nonlymphoid tissues. Comp. Immunol. Microbiol. Infect. Dis. 24, 1-20.
53. Wu, X., Liu, H., Xiao, H., Conway, J. A., Hunter, E., and Kappes, J. C. (1997). Functional RT and IN incorporated into HIV-1 particles independently of the gag/pol precursor. EMBO J. 16, 5113-5122.
54. Wu, X., Wakefield, J. K., Liu, H., Xiao, H., Kralovics, R., Prchal, J. T., and Kappes, J. C. (2000). Development of a novel trans-lentiviral vector that affords predictable safety. Mol. Ther. 2, 47-55.
55. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., and Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotech. 15, 871-875.
56. Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, D., Quiroz, L., Naldini, L., and Trono, D. (1998). Self-inactivating lentivirus vectors for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.
57. Zufferey, R., Donello, J. E., Trono, D., and Hope, T. J. (1999). Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73, 2886-2892.